Spectrum of childhood symptoms caused by SARS-CoV-2 (severe acute respiratory syndrome-2) infection is widening. In contrast to adulthood, where psychiatric disorders caused by SARS-CoV-2 infection are widely known, recognition of such cases in childhood is still quite rare. Recurrent isolated hallucinations caused by SARS-CoV-2 infection in the absence of other neuropsychiatric symptoms are not yet described in this age group. SARS-CoV-2 infection was confirmed as a cause of recurrent isolated hallucinations in a 10-year-old child, which have most likely disappeared as a consequence of corticosteroid treatment. SARS-CoV-2 infection should also be considered in case of an otherwise healthy child with emerging psychiatric symptoms, which may be cured by corticosteroids.
EspositoG.PesceM.SeguellaL.SanseverinoW.LuJ.SarnelliG. (2020). Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion?Brain, Behavior, and Immunity, 87, 93-94. https://doi.org/10.1016/j.bbi.2020.04.060.
2.
FerrandoS. J.KlepaczL.LynchS.TavakkoliM.DornbushR.BaharaniR.SmolinY.BartellA. (2020). COVID-19 psychosis: A potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response?. Psychosomatics, 61(5), 551–555. https://doi.org/10.1016/j.psym.2020.05.012
3.
GaughanM.ConnollyS.O’RiordanS.TubridyN.McGuiganC.KinsellaJ. A. (2021). Pediatric parainfectious encephalitis associated with COVID-19. Neurology, 96(11), 541-544. https://doi.org/10.1212/WNL.0000000000011476.
4.
Huarcaya-VictoriaJ.Meneses-SacoA.Luna-CuadrosM. A. (2020). Psychotic symptoms in COVID-19 infection: a case series from Lima, Peru. Psychiatry Research, 293, 113378. https://doi.org/10.1016/j.psychres.2020.113378.
5.
HutchisonL.PlichtaA. M.LereaY.MadoraM.UshayH. M. (2020). Neuropsychiatric symptoms in an adolescent boy with multisystem inflammatory syndrome in children. Psychosomatics, 61(6), 739–744. https://doi.org/10.1016/j.psym.2020.06.015
6.
JinYYangHJiWWuWChenSZhangWDuanG (2020). Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses, 12(4), 372. https://doi.org/10.3390/v12040372
LiguoroI.PilottoC.BonanniM.FerrariM. E.PusiolA.NocerinoA.VidalE.CogoP. (2020). SARS-COV-2 infection in children and newborns: a systematic review. European Journal of Pediatrics, 179(7), 1029–1046. https://doi.org/10.1007/s00431-020-03684-7
9.
ManjunathaN.MathS.KulkarniG.ChaturvediS. (2011). The neuropsychiatric aspects of influenza/swine flu: A selective review. Industrial Psychiatry Journal, 20(2), 83–90. https://doi.org/10.4103/0972-6748.102479
10.
MaoL.JinH.WangM.HuY.ChenS.HeQ.ChangJ.HongC.ZhouY.WangD.MiaoX.LiY.HuB. (2020). Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurology, 77(6), 683–690. https://doi.org/10.1001/jamaneurol.2020.1127
11.
PatersonR. W.BrownR. L.BenjaminL.NortleyR.WiethoffS.BharuchaT.JayaseelanD. L.KumarG.RaftopoulosR. E.ZambreanuL.VivekanandamV.KhooA.GeraldesR.ChinthapalliK.BoydE.TuzlaliH.PriceG.ChristofiG.MorrowJ.ZandiM. S. (2020). The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain, 143(10), 3104–3120. https://doi.org/10.1093/brain/awaa240
12.
RogersJ. P.ChesneyE.OliverD.PollakT. A.McGuireP.Fusar-PoliP.ZandiM. S.LewisG.DavidA. S. (2020). Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. The Lancet Psychiatry, 7(7), 611–627. https://doi.org/10.1016/S2215-0366(20)30203-0
13.
Sperner-UnterwegerB.KohlC.FuchsD. (2014). Immune changes and neurotransmitters: possible interactions in depression?Progress in Neuro-Psychopharmacology and Biological Psychiatry, 48, 268-276. https://doi.org/10.1016/j.pnpbp.2012.10.006.
14.
TroyerE. A.KohnJ. N.HongS. (2020). Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain, Behavior, and Immunity, 87, 34-39. https://doi.org/10.1016/j.bbi.2020.04.027.
15.
TsatsakisA.CalinaD.FalzoneL.PetrakisD.MitrutR.SiokasV.PennisiM.LanzaG.LibraM.DoukasS. G.DoukasP. G.KavaliL.BukhariA.GadiparthiC.VageliD. P.KofteridisD. P.SpandidosD. A.PaolielloM. M. B.AschnerM.DoceaA. O. (2020). SARS-CoV-2 pathophysiology and its clinical implications: an integrative overview of the pharmacotherapeutic management of COVID-19. Food and Chemical Toxicology, 146, 111769. https://doi.org/10.1016/j.fct.2020.111769.
